Cited by 213Traumatic Brain Injury and Neurovascular DisturbancesNeuroinflammation and Neurodegeneration MechanismsTraumatic Brain Injury Research

NOX2 drives M1-like microglial/macrophage activation and neurodegeneration following experimental traumatic brain injury

Open access
Kumar, Alok, Barrett, James P., Alvarez-Croda, Dulce-Mariely, Stoica, Bogdan A., Faden, Alan I., Loane, David J.·2016·Brain Behavior and Immunity

Abstract

Following traumatic brain injury (TBI), activation of microglia and peripherally derived inflammatory macrophages occurs in association with tissue damage. This neuroinflammatory response may have beneficial or detrimental effects on neuronal survival, depending on the functional polarization of these cells along a continuum from M1-like to M2-like activation states. The mechanisms that regulate M1-like and M2-like activation after TBI are not well understood, but appear in part to reflect the redox state of the lesion microenvironment. NADPH oxidase (NOX2) is a critical enzyme system that generates reactive oxygen species in microglia/macrophages. After TBI, NOX2 is strongly up-regulated in M1-like, but not in M2-like polarized cells. Therefore, we hypothesized that NOX2 drives M1-like neuroinflammation and contributes to neurodegeneration and loss of neurological function after TBI. In the present studies we inhibited NOX2 activity using NOX2-knockout mice or the selective peptide inhibitor gp91ds-tat. We show that NOX2 is highly up-regulated in infiltrating macrophages after injury, and that NOX2 deficiency reduces markers of M1-like activation, limits tissue loss and neurodegeneration, and improves motor recovery after moderate-level control cortical injury (CCI). NOX2 deficiency also promotes M2-like activation after CCI, through increased IL-4Rα signaling in infiltrating macrophages, suggesting that NOX2 acts as a critical switch between M1- and M2-like activation states after TBI. Administration of gp91ds-tat to wild-type CCI mice starting at 24h post-injury reduces deficits in cognitive function and increased M2-like activation in the hippocampus. Collectively, our data indicate that increased NOX2 activity after TBI drives M1-like activation that contributes to inflammatory-mediated neurodegeneration, and that inhibiting this pathway provides neuroprotection, in part by altering M1-/M2-like balance towards the M2-like neuroinflammatory response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2016.07.158

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic deletion or pharmacological inhibition of NOX2 in a mouse model of traumatic brain injury (TBI) demonstrates attenuation of pro-inflammatory microglial phenotype, indicated by reduced expression of cytokines IL1β, IL6 and TNFα 1-day post-injury.

    “Genetic deletion or pharmacological inhibition of NOX2 in a mouse model of traumatic brain injury (TBI) demonstrates attenuation of pro-inflammatory microglial phenotype, indicated by reduced expression of cytokines, including IL1β, IL6 and TNFα, 1-day post-injury [88].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 70 · Cited by 213

Authors
Kumar, A., Barrett, J. P., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J.
Affiliations
University of Maryland, Baltimore (US)
Corresponding author
Loane, David J.
Venue
Brain Behavior and Immunity
Publisher
Elsevier BV
Published
2016-11
Volume
58
Pages
291-309
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2499640845
Cited by
213
References
70
Citations by year
2026: 21 · 2025: 19 · 2024: 12 · 2023: 14 · 2022: 24 · 2021: 35 · 2020: 29 · 2019: 14 · 2018: 23 · 2017: 20 · 2016: 2
FWCI
14.77
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH (R01NS082308, R01NS037313)
  • NIA (P30-AG028747)
  • CONACYT (249772/389071)
Topics
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
Keywords
NOX2, NADPH oxidase, traumatic brain injury, microglial activation, macrophage polarization, neuroinflammation, neurodegeneration, infiltrating macrophages, reactive oxygen species, motor recovery, cognitive impairment, hippocampus, neuroprotection
MeSH terms
Brain Injuries, Traumatic, NADPH Oxidase 2, Animals, Cerebral Cortex, Encephalitis, Macrophages, Male, Mice, Inbred C57BL, Microglia, Mice, Knockout, Mice, Spatial Memory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review